Sponsor or institution

Clinical trials and research at Allist Pharmaceuticals, Inc.

• 9Clinical trials
• 1Country

Newest trials

All recruiting trials (9)

• Firmonertinib versus placebo as additional treatment after surgery for stage IB–IIIB non‑small cell lung cancer with uncommon EGFR mutations

  This trial will test whether taking firmonertinib after complete lung cancer surgery helps prevent recurrence in people with stage IB–IIIB NSCLC that has uncommon EGFR mutations.

  Recruiting at 2 sites Phase 3 Allist Pharmaceuticals, Inc. · Beijing, Beijing Municipality and 1 other locations · NCT07010419

• Evaluating furmonertinib with chemotherapy versus osimertinib for lung cancer with brain metastases

  This study is testing whether a new drug called furmonertinib combined with chemotherapy works better than osimertinib alone for people with lung cancer that has spread to the brain.

  Recruiting Phase 3 Allist Pharmaceuticals, Inc. · Guangdong, Guangzhou · NCT06970639

• Comparing firmonertinib to chemotherapy for advanced lung cancer with specific mutations

  This study is testing whether a new drug called firmonertinib can work better than standard chemotherapy for people with advanced lung cancer who have specific genetic mutations.

  Recruiting at 2 sites Phase 3 Allist Pharmaceuticals, Inc. · Beijing, Beijing Municipality and 1 other locations · NCT06956001

• Evaluating AST2303 Tablets in Patients with Advanced Lung Cancer

  This study is testing if AST2303 tablets are safe and effective for people with advanced non-small cell lung cancer.

  Recruiting Phase 1 Allist Pharmaceuticals, Inc. · Shanghai, Shanghai Municipality · NCT06955988

• Combining JAB-21822 and JAB-3312 for advanced lung cancer with KRAS mutation

  This study is testing if a new combination of JAB-21822 and JAB-3312 can help people with advanced lung cancer that has a specific KRAS mutation do better than the usual treatment.

  Recruiting at 6 sites Phase 3 Allist Pharmaceuticals, Inc. · Hefei, Anhui and 36 other locations · NCT06416410

• Evaluating JAB-21822 for pancreatic cancer and other solid tumors with a specific mutation

  This study is testing a new drug called Glecirasib to see if it can help adults with advanced pancreatic cancer or other solid tumors that have a specific mutation and who haven't had success with other treatments.

  Recruiting at 29 sites Phase 2 Allist Pharmaceuticals, Inc. · Hefei, Anhui and 30 other locations · NCT06008288

• Testing JAB-21822 and JAB-3312 in patients with advanced solid tumors and KRAS p.G12C mutation

  This study is testing a new combination of drugs, JAB-21822 and JAB-3312, to see if it helps people with advanced solid tumors that have a specific KRAS mutation.

  Recruiting at 3 sites Phase 1/2 Allist Pharmaceuticals, Inc. · Hefei, Anhui and 26 other locations · NCT05288205

• Evaluating JAB-21822 for advanced lung cancer with specific mutations

  This study is testing a new treatment called JAB-21822 to see if it can help people with advanced lung cancer who have certain genetic mutations.

  Recruiting Phase 1/2 Allist Pharmaceuticals, Inc. · Beijing, Beijing Municipality and 20 other locations · NCT05276726

• Assessing Furmonertinib for Non-small Cell Lung Cancer After Surgery

  This study is testing if a new drug called Furmonertinib can help people with stage II-IIIA non-small cell lung cancer feel better after their surgery compared to a placebo.

  Recruiting Phase 3 Allist Pharmaceuticals, Inc. · Suzhou, Jiangsu · NCT04853342

Quick answers

How many clinical trials run by Allist Pharmaceuticals, Inc. are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 5, Phase 1/2: 2, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →